title: [Metabolic syndrome in patients with schizophrenia and antipsychotic treatment].
abstract: Patients with schizophrenia have a shorter life expectancy and their risk of dying from a cardiovascular disease is higher than the general population. Both facts have been attributed to the raised presence of metabolic syndrome. There is a big amount of scientific publications that deals with the relationship between schizophrenia, antipsychotic treatment, and the development of metabolic syndrome. There is also information about recommendations and clinical guides to achieve an adequate prevention, screening, and treatment of the disease. The aim of this review is to update the current information about this issue and to understand related etiologic factors, differences between antipsychotic drugs, and the current recommendations for patient's care.
authors: Servicio de Psiquiatría, Corporació Sanitària Parc Taulí, Institut Universitari Parc Taulí, Universitat Autònoma de Barcelona, Sabadell, Barcelona, España.
authors: Eva
authors: E
authors: Aguilar
authors: Ramón
authors: R
authors: Coronas
authors: Assumpta
authors: A
authors: Caixàs
mesh_terms: D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001569:Benzodiazepines / Q000009:adverse effects / Q000627:therapeutic use; D001786:Blood Glucose / Q000032:analysis; D002318:Cardiovascular Diseases / Q000209:etiology / Q000401:mortality; D003024:Clozapine / Q000009:adverse effects / Q000627:therapeutic use; D015897:Comorbidity; D005500:Follow-Up Studies; D006801:Humans; D007031:Hypothalamus / Q000187:drug effects / Q000503:physiopathology; D015994:Incidence; D008017:Life Expectancy; D050356:Lipid Metabolism / Q000187:drug effects; D024821:Metabolic Syndrome / Q000139:chemically induced* / Q000188:drug therapy / Q000453:epidemiology / Q000503:physiopathology / Q000517:prevention & control; D056128:Obesity, Abdominal / Q000139:chemically induced / Q000453:epidemiology; D000077152:Olanzapine; D017410:Practice Guidelines as Topic; D012559:Schizophrenia / Q000188:drug therapy* / Q000453:epidemiology; D015430:Weight Gain
chemical_list: D014150:Antipsychotic Agents; D001786:Blood Glucose; D001569:Benzodiazepines; D003024:Clozapine; D000077152:Olanzapine